Panagora Asset Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Panagora Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,019	Closed	-$7K	–	2948
2021 Q1	$7K	Sell	6,019 -2,747	-31%	-$5.09K	﹤0.01%	2512
2020 Q4	$17K	Buy	8,766 +1,188	+16%	+$2.05K	﹤0.01%	2218
2020 Q3	$13K	Buy	+7,578	New	+$12.4K	﹤0.01%	2286

Other funds holding STLNW

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Panagora Asset Management's STLNW Position: Q2 2021 in Review

Panagora Asset Management sold out of Starling Oncology, Inc. Warrant (STLNW) in Q2 2021, closing a stake of 6,019 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in STLNW in Q3 2020 and held it in 3 quarters. The position peaked at $17K in Q4 2020. 26 funds tracked by Wall St. Rank hold STLNW as of Q2 2021.

Panagora Asset Management reported no remaining Starling Oncology, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Panagora Asset Management sold 6,019 Starling Oncology, Inc. Warrant shares in Q2 2021, an estimated $7K.
Panagora Asset Management first reported a position in Starling Oncology, Inc. Warrant in Q3 2020 and held it in 3 quarters.
Panagora Asset Management's Starling Oncology, Inc. Warrant position peaked at $17K in Q4 2020.
26 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.